Zika R&D Landscape Evolving Rapidly
This article was originally published in Scrip
Executive Summary
Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases (NIAID), on Feb. 17 said he's hearing weekly, if not daily, from companies interested in potentially partnering with his agency on a Zika virus vaccine, telling reporters he's dealing with at least three "major" biopharmaceutical players, although he declined to identify them.